Money Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. – Barron’s agosto 31, 2026 0 FacebookTwitterPinterestWhatsApp Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. – Barron’s Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What It Means for the Stock. Barron’s Quero saber mais sobre como ter sucesso no mundo digital